Optimizing care for patients with non-traumatic intracerebral hemorrhage
Optimization of the Management of Non-Traumatic Intracerebral Hemorrhage (OPT-ICH)
This study is testing a new emergency care plan for patients with non-traumatic brain bleeding to see if it can improve their treatment and recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Tours Academic / other |
| Locations | 3 sites (Angers and 2 other locations) |
| Trial ID | NCT06802588 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the management of patients with non-traumatic intracerebral hemorrhage (ICH) at the University Hospital of Tours. It includes a retrospective analysis of patients admitted between 2018-2021 and a prospective evaluation of current management practices. The study focuses on implementing a standardized protocol for emergency care, including rapid imaging, antihypertensive treatment, and follow-up evaluations. The goal is to improve patient outcomes by analyzing and optimizing the acute management of ICH.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are admitted urgently to the University Hospital of Tours with a confirmed diagnosis of ICH.
Not a fit: Patients who have opted out of data collection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved survival rates and reduced disability for patients suffering from ICH.
How similar studies have performed: Preliminary data from other studies suggest that improved management protocols for ICH have led to better survival rates, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged over 18 years * emergency admission to the University Hospital of Tours * having an ICH on imaging performed upon admission (CT scan or MRI) at the University Hospital of Tours Exclusion criteria : \- Patient who has given their opposition to the collection of their data
Where this trial is running
Angers and 2 other locations
- University Hospital of Angers — Angers, France (Recruiting)
- University Hospital of Poitiers — Poitiers, France (Recruiting)
- University Hospital Center of Tours — Tours, France (Recruiting)
Study contacts
- Principal investigator: Marco PASI, MD, PHD — neurovascular unit, neurology department, CHRU Tours
- Study coordinator: Marco PASI, MD, PHD
- Email: M.PASI@chu-tours.fr
- Phone: +33 0247478024
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.